Evidence map›Paper›PMID 33893902›Full record

ArticleGeroScience2021

T lymphocyte depletion ameliorates age-related metabolic impairments in mice.

Daniel W Trott, Md Torikul Islam, David J Buckley, Anthony J Donato, Tavia Dutson, Eric S Sorensen, Jinjin Cai, Venkateswara R Gogulamudi, Tam T T Phuong, Lisa A Lesniewski

Open access · greenAbstract read
In one paragraph

Article in GeroScience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Augmented T-cell mitochondrial reactive oxygen species in adults with major depressive disorder.American journal of physiology. Heart and circulatory physiology · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Daniel W Trott *Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Md Torikul Islam *Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, UT, USA.
David J BuckleyDepartment of Kinesiology, University of Texas at Arlington, Arlington, TX, USA.
Anthony J DonatoDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Tavia DutsonDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Eric S SorensenDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Jinjin CaiDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Venkateswara R GogulamudiDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Tam T T PhuongDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Lisa A LesniewskiDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, USA. Lisa.Lesniewski@utah.edu.ORCID http://orcid.org/0000-0002-2138-1450
University of Utah · USThe University of Texas at Arlington · US

Funding

IMPACT OF T CELLS ON AGE-RELATED VASCULAR DYSFUNCTION: A TRANSLATIONAL APPROACH - DIVERSITY SUPPLEMENTR01AG060395 · NIA · UNIVERSITY OF UTAH · PI DONATO, ANTHONY JOHN · 2019 to 2023
$2.5M
Integrative Mechanisms of Vascular AgingR01AG077751 · NIA · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Anthony John Donato, Lisa A Lesniewski · 2023 to 2026
$1.8M
Mechanisms of augmented atherosclerotic progression with agingR01AG048366 · NIA · UNIVERSITY OF UTAH · PI LESNIEWSKI, LISA A · 2016 to 2020
$1.7M
T cells mediate age related arterial dysfunctionK01AG061271 · NIA · UNIVERSITY OF TEXAS ARLINGTON · PI TROTT, DANIEL · 2019 to 2023
$635k
Role of ARF6 in atherosclerotic burden and severityI01BX004492 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI LESNIEWSKI, LISA A · 2020 to 2023
–
BLRD VA I01 BX004492NIA NIH HHS K01 AG061271NIA NIH HHS R01 AG048366NIA NIH HHS R01 AG060395NIA NIH HHS R01 AG077751NIH HHS K01 AG061271
6 · The paper itself

Abstract

Both glucose tolerance and adaptive immune function exhibit significant age-related alterations. The influence of the immune system on obesity-associated glucose intolerance is well characterized; however, whether the immune system contributes to age-related glucose intolerance is not as well understood. Here, we report that advancing age results in an increase in T cell infiltration in the epididymal white adipose tissue (eWAT), liver, and skeletal muscle. Subtype analyses show that both CD4+, CD8+ T cells are greater with advancing age in each of these tissues and that aging results in a blunted CD4 to CD8 ratio. Anti-CD3 F(ab')2 fragments depleted CD4+ and CD8+ cells in eWAT, CD4+ cells only in the liver, and did not deplete quadriceps T cells. In old mice, T cells producing both interferon-γ and tumor necrosis factor-α are accumulated in the eWAT and liver, and a greater proportion of skeletal muscle T cells produced interferon-γ. Aging resulted in increased proportion and numbers of T regulatory cells in eWAT, but not in the liver or muscle. Aging also resulted in greater numbers of eWAT and quadriceps CD206- macrophages and eWAT, liver and quadriceps B cells; neither cell type was altered by anti-CD3 treatment. Anti-CD3 treatment improved glucose tolerance in old mice and was accompanied by improved signaling related to liver and skeletal muscle insulin utilization and decreased gluconeogenesis-related gene expression in the liver. Our findings indicate a critical role of the adaptive immune system in the age-related metabolic dysfunction.

Indexed as

CD4-Positive T-LymphocytesCD8-Positive T-LymphocytesAdipose Tissue, WhiteAnimalsLymphocyte DepletionMiceMice, Inbred C57BLAdipose tissueGlucose intoleranceLiverMacrophagesSkeletal muscleT lymphocyte

Identifiers

PMID33893902
PMCPMC8190228
OpenAlexW3154862483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.